124 related articles for article (PubMed ID: 17983191)
1. [Seroepidemiology studies on population immune background to viral hepatitis B].
Duca E; Romaniuc A; Trifan M; Butur D; Ivan A
Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):494-9. PubMed ID: 17983191
[TBL] [Abstract][Full Text] [Related]
2. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
[TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
Amini S; Mahmoodi MF; Andalibi S; Solati AA
J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
[TBL] [Abstract][Full Text] [Related]
4. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
Gupta S; Singh S
BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of markers of hepatitis B in the adult German population.
Jilg W; Hottenträger B; Weinberger K; Schlottmann K; Frick E; Holstege A; Schölmerich J; Palitzsch KD
J Med Virol; 2001 Feb; 63(2):96-102. PubMed ID: 11170044
[TBL] [Abstract][Full Text] [Related]
6. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
[TBL] [Abstract][Full Text] [Related]
7. Community-based research: cost of the tests used for anti-HBc total seropositivity only and hepatitis B screening.
Ozkan S; Atak A; Bozdayi G; Turkcuoglu S; Maral I
Trans R Soc Trop Med Hyg; 2010 Dec; 104(12):782-6. PubMed ID: 20889180
[TBL] [Abstract][Full Text] [Related]
8. HBV and HCV infection in Japanese dental care workers.
Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
[TBL] [Abstract][Full Text] [Related]
9. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
[TBL] [Abstract][Full Text] [Related]
10. The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus.
Kafatos G; Anastassopoulou C; Nardone A; Andrews N; Barbara C; Boot HJ; Butur D; Davidkin I; Gelb D; Griskevicius A; Hesketh L; Icardi G; Jones L; Kra-Oz Z; Miller E; Mossong J; Nemecek V; de Ory F; Sobotová Z; Thierfelder W; Van Damme P; Hatzakis A
J Viral Hepat; 2007 Apr; 14(4):260-8. PubMed ID: 17381718
[TBL] [Abstract][Full Text] [Related]
11. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
12. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy).
Majori S; Baldo V; Tommasi I; Malizia M; Floreani A; Monteiro G; Ferrari A; Accordini A; Guzzo P; Baldovin T
J Travel Med; 2008; 15(5):323-7. PubMed ID: 19006505
[TBL] [Abstract][Full Text] [Related]
14. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
15. Minimization of hepatitis B infection by a 25-year universal vaccination program.
Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS
J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of hepatitis B virus (HBV) among Turkish immigrants in Germany.
Burgazli KM; Mericliler M; Sen C; Tuncay M; Gökce Y; Nayir B; Klör HU; Sinterhauf K; Karatay E; Bilgin Y
Eur Rev Med Pharmacol Sci; 2014; 18(6):869-74. PubMed ID: 24706312
[TBL] [Abstract][Full Text] [Related]
17. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
18. [Seroprevalence of hepatitis B virus in children with cancer under chemotherapy in 6 hospitals of Santiago, Chile].
Zubieta A M; Santolaya ME; Hurtado C; Alvarez AM; Avilés CL; Becker A; Brahm J; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T
Rev Med Chil; 2009 Jul; 137(7):906-11. PubMed ID: 19802418
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the prevalence of HBV markers relevant to the risk of reactivation of infection in patients with hematologic diseases].
Kopacz A; Bielecka A; Mikulska M; Grabarczyk P; Zwolińska P; Wojciechowska B; Łetowska M; Kisiel E; Warzocha K; Ceglarek B; Szczepanik AB; Szczepiński A; Owczarska K; Pielaciński K; Brojer E
Przegl Epidemiol; 2012; 66(1):1-5. PubMed ID: 22708290
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang vaccine in adolescents from low income families in Central Brazil.
Oliveira MD; Martins RM; Matos MA; Ferreira RC; Dias MA; Carneiro MA; Junqueira AL; Teles SA
Mem Inst Oswaldo Cruz; 2006 May; 101(3):251-6. PubMed ID: 16862317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
